KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to $6.9 billion.

  • Edwards Lifesciences' Non-Current Assets rose 1072.8% to $6.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $27.4 billion, marking a year-over-year increase of 2061.7%. This contributed to the annual value of $6.8 billion for FY2024, which is 2707.46% up from last year.
  • Edwards Lifesciences' Non-Current Assets amounted to $6.9 billion in Q3 2025, which was up 1072.8% from $6.9 billion recorded in Q2 2025.
  • In the past 5 years, Edwards Lifesciences' Non-Current Assets ranged from a high of $6.9 billion in Q3 2025 and a low of $4.1 billion during Q1 2021
  • Over the past 5 years, Edwards Lifesciences' median Non-Current Assets value was $5.3 billion (recorded in 2023), while the average stood at $5.5 billion.
  • Per our database at Business Quant, Edwards Lifesciences' Non-Current Assets soared by 2835.92% in 2021 and then tumbled by 235.25% in 2022.
  • Over the past 5 years, Edwards Lifesciences' Non-Current Assets (Quarter) stood at $5.3 billion in 2021, then dropped by 2.35% to $5.2 billion in 2022, then increased by 2.52% to $5.3 billion in 2023, then rose by 27.07% to $6.8 billion in 2024, then rose by 2.12% to $6.9 billion in 2025.
  • Its Non-Current Assets was $6.9 billion in Q3 2025, compared to $6.9 billion in Q2 2025 and $6.8 billion in Q1 2025.